Použití esmololu v léčbě paroxysmální fibrilace síní u nemocné se subklinickou hyperthyreozou
| Title in English | Esmolol in the treatment of paroxysmal atrial fibrilation in patient with subclinic hypertherosis |
|---|---|
| Authors | |
| Year of publication | 2012 |
| Type | Article in Periodical |
| Magazine / Source | Farmakoterapie |
| Citation | |
| Keywords | esmolol, hyperthyreosis |
| Description | Prevalence of atrial fibrillation and supraventricular tachycardia in patients with hyperthyroidism is from 2-20%, and its incidence increases with age. Mild and subclinical forms of hyperthyroidism have the same relative risk of atrial fibrillation as a developed form. Ultra-short-acting beta blocker esmolol is a suitable product for the treatment of fibrillation in patients with hyperthyroidism |